Literature DB >> 27530222

The multifaceted role of metalloproteinases in physiological and pathological conditions in embryonic and adult brains.

Maria Egle De Stefano1, Maria Trinidad Herrero2.   

Abstract

Matrix metalloproteinases (MMPs) are a large family of ubiquitous extracellular endopeptidases, which play important roles in a variety of physiological and pathological conditions, from the embryonic stages throughout adult life. Their extraordinary physiological "success" is due to concomitant broad substrate specificities and strict regulation of their expression, activation and inhibition levels. In recent years, MMPs have gained increasing attention as significant effectors in various aspects of central nervous system (CNS) physiology. Most importantly, they have been recognized as main players in a variety of brain disorders having different etiologies and evolution. A common aspect of these pathologies is the development of acute or chronic neuroinflammation. MMPs play an integral part in determining the result of neuroinflammation, in some cases turning its beneficial outcome into a harmful one. This review summarizes the most relevant studies concerning the physiology of MMPs, highlighting their involvement in both the developing and mature CNS, in long-lasting and acute brain diseases and, finally, in nervous system repair. Recently, a concerted effort has been made in identifying therapeutic strategies for major brain diseases by targeting MMP activities. However, from this revision of the literature appears clear that MMPs have multifaceted functional characteristics, which modulate physiological processes in multiple ways and with multiple consequences. Therefore, when choosing MMPs as possible targets, great care must be taken to evaluate the delicate balance between their activation and inhibition and to determine at which stage of the disease and at what level they become active in order maximize chances of success.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Brain disorders; Development; Metalloproteinases; Nervous system repair; Neurodegenerative diseases; Neuroinflammation

Mesh:

Substances:

Year:  2016        PMID: 27530222     DOI: 10.1016/j.pneurobio.2016.08.002

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  10 in total

1.  MT1-MMP deficiency leads to defective ependymal cell maturation, impaired ciliogenesis, and hydrocephalus.

Authors:  Zhixin Jiang; Jin Zhou; Xin Qin; Huiling Zheng; Bo Gao; Xinguang Liu; Guoxiang Jin; Zhongjun Zhou
Journal:  JCI Insight       Date:  2020-05-07

2.  Microvasculature of the Mouse Cerebral Cortex Exhibits Increased Accumulation and Synthesis of Hyaluronan With Aging.

Authors:  May J Reed; Robert B Vernon; Mamatha Damodarasamy; Christina K Chan; Thomas N Wight; Itay Bentov; William A Banks
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-06-01       Impact factor: 6.053

Review 3.  Role of Microgliosis and NLRP3 Inflammasome in Parkinson's Disease Pathogenesis and Therapy.

Authors:  Fillipe M de Araújo; Lorena Cuenca-Bermejo; Emiliano Fernández-Villalba; Silvia L Costa; Victor Diogenes A Silva; Maria Trinidad Herrero
Journal:  Cell Mol Neurobiol       Date:  2021-01-02       Impact factor: 5.046

4.  A New Tool to Study Parkinsonism in the Context of Aging: MPTP Intoxication in a Natural Model of Multimorbidity.

Authors:  Lorena Cuenca-Bermejo; Elisa Pizzichini; Valeria C Gonçalves; María Guillén-Díaz; Elena Aguilar-Moñino; Consuelo Sánchez-Rodrigo; Ana-María González-Cuello; Emiliano Fernández-Villalba; María Trinidad Herrero
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

Review 5.  Can tetracyclines ensure help in multiple sclerosis immunotherapy?

Authors:  Pedro Víctor-Carvalho; Rodolfo Thome; Catarina Rapôso
Journal:  J Clin Transl Res       Date:  2021-02-03

6.  ApoSOD1 lacking dismutase activity neuroprotects motor neurons exposed to beta-methylamino-L-alanine through the Ca2+/Akt/ERK1/2 prosurvival pathway.

Authors:  Tiziana Petrozziello; Agnese Secondo; Valentina Tedeschi; Alba Esposito; MariaJosè Sisalli; Antonella Scorziello; Gianfranco Di Renzo; Lucio Annunziato
Journal:  Cell Death Differ       Date:  2017-01-13       Impact factor: 15.828

Review 7.  Nerve, Muscle, and Synaptogenesis.

Authors:  Lauren Eric Swenarchuk
Journal:  Cells       Date:  2019-11-16       Impact factor: 6.600

8.  Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment.

Authors:  Aditya N Bade; JoEllyn M McMillan; Yutong Liu; Benson J Edagwa; Howard E Gendelman
Journal:  Mol Neurobiol       Date:  2021-08-14       Impact factor: 5.590

9.  Combined 1-Deoxynojirimycin and Ibuprofen Treatment Decreases Microglial Activation, Phagocytosis and Dopaminergic Degeneration in MPTP-Treated Mice.

Authors:  Tcs Costa; E Fernandez-Villalba; V Izura; A M Lucas-Ochoa; N J Menezes-Filho; R C Santana; M D de Oliveira; F M Araújo; C Estrada; Vda Silva; S L Costa; M T Herrero
Journal:  J Neuroimmune Pharmacol       Date:  2020-06-21       Impact factor: 4.147

10.  A Hydroxypyrone-Based Inhibitor of Metalloproteinase-12 Displays Neuroprotective Properties in Both Status Epilepticus and Optic Nerve Crush Animal Models.

Authors:  Jonathan Vinet; Anna-Maria Costa; Manuel Salinas-Navarro; Giuseppina Leo; Lieve Moons; Lutgarde Arckens; Giuseppe Biagini
Journal:  Int J Mol Sci       Date:  2018-07-25       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.